Compared to healthy children, children being treated for cancer were known to mount weaker immune responses to the flu vaccine. However, previous research showed that following vaccination, 28 to 100 percent of pediatric cancer patients developed ...and more »
Celgene Blood Cancer Treatment: Just A Tip Of Biotech Stock's ...
Celgene became a biotech juggernaut thanks to a treatment for tricky blood cancers. Now drugs battling lupus, MS and more are on the stock's potential hit list.and more »
No comments:
Post a Comment